Infographic.tif (18.98 MB)
Glucagon-Like Peptide-1 Receptor Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Narrative Review of the Key Evidence with Practical Considerations
media
posted on 2022-02-07, 17:58 authored by José L. Górriz, Irene Romera, Amelia Cobo, Phillipe D. O’Brien, Juan F. Merino-TorresThe above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.
